TVRD
Tvardi Therapeutics
TVRD
TVRD
70 hedge funds and large institutions have $120M invested in Tvardi Therapeutics in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
66% less call options, than puts
Call options by funds: $26K | Put options by funds: $76K
72% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 32
Holders
70
Holding in Top 10
2
Calls
$26K
Puts
$76K
Top Buyers
| 1 | +$34.9M | |
| 2 | +$4.26M | |
| 3 | +$642K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$350K |
| 5 |
NPC
National Planning Corporation
El Segundo,
California
|
+$332K |
Top Sellers
| 1 | -$9.9M | |
| 2 | -$7.54M | |
| 3 | -$4.11M | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$866K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$559K |